1/18/2022 | 3002150000 | RETAIL MEDICINE FOR MEDICAL USE (VED 1H): SIMPONI (GOLIMUMAB) SOLUTION FOR SUBCUTANEOUS INTRODUCTION, 50 MG/0.5 ML (PEN) 0.5 ML X 1 (CARDBOARD PACK) - 6002 PACK, SERIES 21C1064 YEAR.YEAR.4 , GROSS WEIGHT | 620.21 | 3681403 | United States of America | MOSCOW RUSSIA | MSD PHARMASYUTICALS LLC |
1/17/2022 | 3002150000 | MEDICINES FOR RETAIL: RESTASIS (CYCLOSPORINE) EYE DROPS 0.05% (BOTTLE) 0.4 ML X 30 (CARDBOARD PACK) - 4104 UP. SERIES T3932 IS EXPIRED UNTIL 08.2023 ACTIVE SUBSTANCE: CYCLOSPORINE. | 279 | 100874.9 | United States of America | MOSCOW RUSSIA | ALLERGAN CIS SARL LLC |
1/18/2022 | 3002150000 | RETAIL MEDICINES: FAZENRA (BENRALIZUMAB) SUBCUTANEOUS SOLUTION, 30 MG/ML (SYRINGE) 1.0 ML X 1 (CARDBOARD PACK) - 1393 PK, SERIES NN0121 EXPIRY 06.2024, GROSS WEIGHT WITH 5.106 PALLETS | 175.24 | 2200723 | United States of America | MOSCOW RUSSIA | ASTRAZENEKA PHARMACIES LLC |
1/18/2022 | 3002150000 | SAR441344 / PLACEBO, 150 MG/ML SC/IV SOLUTION, 2 ML EA, 1 BOTTLE PER CARTON, 270 BOTTLE TOTAL, SERIES IP026089, EXPIRY 11/2022,: | 8.37 | 30750.8 | United States of America | UNKNOWN | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/18/2022 | 3002150000 | SAR440340/ITEPECIMAB/PLACEBO, 150 MG/ML SC INJECTION SOLUTION IN 2 ML PRE-FILLED SYRINGE, TOTAL 156 SYRINGES, SERIES IP025859, EXPIRY 12/2022, : | 6.08 | 25967 | United States of America | UNKNOWN | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/17/2022 | 3002150000 | SAR153191, (SARILUMAB), 175 MG/ML SC SOLUTION IN 2.7 ML VIAL, 100 VIALS TOTAL, SERIES IP024923, EXPIRY 2/2023, : | 2.9 | 35441.3 | United States of America | UNKNOWN | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
1/24/2022 | 3002150000 | SAR153191 (SARILUMAB), SC SOLUTION 175 MG/ML IN 2.7 ML BOTTLE, 1 BOTTLE PER PACK, 200 BOTTLE TOTAL, SERIES IP025136, EXPIRY DATE 02/2023, : | 5.6 | 11811.5 | United States of America | Unknown | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |